Neuraptive Therapeutics Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX001 for the Adjunct Treatment of Transected Peripheral Nerves
Neuraptive Therapeutics Inc. a leader in nerve repair and regeneration is pleased to announce a significant milestone in transforming the treatment paradigm for peripheral nerve injuries.
United States Evan Tzanis Robert Radie Neuraptive Therapeutics Inc Chief Operating Officer Neuraptive Therapeutics
Source: businesswireindia.com